Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Canada / Steve N. Slilaty

Canada & Steve N. Slilaty

1 shared events · Importance 3 · Last updated Jun 25, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
35
Regulatory
Sunshine Biopharma Anastrozole Canadian Approval
Canada: Canada is the market where Sunshine Biopharma received regulatory approval for its generic Anastrozole tablets, representing a significant market for the company's expansion.
Steve N. Slilaty: Steve N. Slilaty, CEO of Sunshine Biopharma, expressed satisfaction with the approval of Anastrozole, highlighting its importance for the company's generics portfolio and commitment to affordable medicines.
Jun 25, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how Canada and Steve N. Slilaty interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.